NeurOptimal / Neurofeedback Research
CHEMO BRAIN NeurOptimal / Neurofeedback Research
CHEMO BRAIN (Cancer therapy)
The Effect of EEG Biofeedback on Reducing Postcancer Cognitive Impairment
Jean Alvarez, EdD, Fremonta L. Meyer, David L. Granoff and Allan Lundy
Integr Cancer Ther published online 12 April 2013, DOI: 10.1177/1534735413477192
The abstract is available here where the full article is available for purchase. Alternatively you may email Jean Alvarez directly for a full copy.
>> Read More
Efficacy of EEG Biofeedback in Addressing Cognitive Dysfunction in Cancer Survivors
This study examined the efficacy of EEG biofeedback (neurofeedback) in addressing the cognitive sequelae of cancer therapy, commonly known as “chemobrain” or “chemofog.” Approximately fifty percent of breast cancer survivors exhibit cognitive impairment within three weeks of beginning chemotherapy, and half of those have not recovered one year later. Neurofeedback, unlike compensatory strategies currently recommended by the National Cancer Institute and major cancer centers, has the potential to restore cognitive function.
Jean Alvarez, EdD, David L. Granoff, Allan Lundy.
>> Read More
- NeurOptimal / Neurofeedback Testimonial & Review
- Fee Agreement & Polices for NeurOptimal / Neurofeedback Training
- Combining Counseling / Psychotherapy and Neurofeedback – NeurOptimal
- NeurOptimal / Neurofeedback Blog
- NeurOptimal / Neurofeedback Videos
- NeurOptimal / Neurofeedback Research
- Neurofeedback / NeurOptimal Explore
- NeurOptimal® Survey
- NeurOptimal and Neurofeedback Resources